Machine Learning Antibody Design for Multi-Property Optimization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing antibodies struggle to optimize multiple characteristics such as expression level, binding activity, stability, and solubility simultaneously, often resulting in trade-offs due to conflicting measurement data and limited dataset quality.

Innovation Solution

A method involving the creation of a mutant library by modifying residues to the highest appearance frequency, scoring multiple characteristics as a unified value, and using machine learning to rank and select antibodies optimized for these traits.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If mutation is introduced into CDR regions to improve binding activity, then binding activity is improved, but structural stability deteriorates

Engineering Contradiction:
Improvebinding activityVSAvoidstructural stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent applies local quality by introducing mutations specifically into CDR regions (complementarity-determining regions) which are responsible for antigen binding, while keeping framework regions relatively intact. This allows improvement of binding activity through localized changes without compromising overall structural stability, as the framework regions provide the stable scaffold necessary for maintaining protein fold and stability.

Inventive Principle:
Principle #3Local quality

2Stability of the object's composition

If mutation is introduced into framework regions to improve structural stability, then structural stability is improved, but binding activity deteriorates

Engineering Contradiction:
Improvestructural stabilityVSAvoidbinding activity
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent strategically limits mutations in framework regions to only those positions that are critical for structural stability, while avoiding positions that could affect CDR conformation and binding activity. This localized approach allows structural improvement without sacrificing binding function.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent performs preliminary computational analysis to identify framework region positions that are most critical for structural stability before introducing mutations. This allows pre-screening of mutation sites to ensure that stability-improving mutations will not adversely affect binding activity.

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If multiple characteristics are optimized simultaneously using traditional methods, then optimization coverage is improved, but measurement precision deteriorates due to trade-offs

Engineering Contradiction:
Improveoptimization coverageVSAvoidmeasurement precision
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent introduces a machine learning model as an intermediary that integrates multiple measurement data types (expression level, binding activity, solubility, stability) and predicts their combined effects on antibody characteristics. This intermediary system resolves trade-offs by identifying mutation combinations that simultaneously improve multiple characteristics without the precision loss associated with traditional sequential optimization methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the optimization approach from sequential single-parameter optimization to simultaneous multi-parameter optimization using computational methods. By evaluating multiple characteristics together through machine learning predictions, the system achieves precise optimization across all parameters without the trade-offs inherent in sequential methods.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentEP4625420A1Antibody design method through machine learning
Publication Date: 2025.10.01 REVOLKA LTD
  • EP4625420A1 patent drawingFigure 1
  • EP4625420A1 patent drawingFigure 2
  • EP4625420A1 patent drawingFigure 3

AI summary

The present invention relates to a method of producing an antibody through machine learning. More specifically, the present invention relates to a method of producing an antibody that is optimized for a plurality of characteristics including at least two of an expression level, binding activity, stability, and solubility; and the like.